Panbela Therapeutics Inc. buy Roth Mkm
Start price
18.12.23
/
50%
€90.36
Target price
18.12.24
€22.90
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 18.12.24. The prediction end date can be changed by Roth_Mkm at any time.Performance without dividends (%)
Name | 1w | 1m |
---|---|---|
Panbela Therapeutics Inc. | - | - |
iShares Core DAX® | 4.094% | 3.543% |
iShares Nasdaq 100 | 1.424% | 0.512% |
iShares Nikkei 225® | -1.572% | -4.633% |
iShares S&P 500 | 1.822% | 0.963% |
Comments by Roth_Mkm for this prediction
In the thread Panbela Therapeutics Inc. diskutieren
Panbela Therapeutics, Inc. (NASDAQ: PBLA) had its "buy" rating re-affirmed by analysts at Roth Mkm. They now have a $25.00 price target on the stock.
Ratings data for PBLA provided by MarketBeat
Stopped prediction by Roth_Mkm for Panbela Therapeutics Inc.
Panbela Therapeutics Inc.
Start price
Target price
Perf. (%)
€90.36
27.03.24
27.03.24
€23.10
27.03.25
27.03.25
-
15.12.23
15.12.23
Panbela Therapeutics Inc.
Start price
Target price
Perf. (%)
€90.36
05.02.24
05.02.24
€23.26
05.02.25
05.02.25
-
15.12.23
15.12.23